KFKolbe Roche Fernández

Kolbe Roche Fernández

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kolbe Roche Fernández has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Periodontal disease and glaucoma. A systematic review and Meta-Analysis

    by Anderson Vilchez-Chavez, Rachid Bouchikh-El Jarroudi, Isabel Silva-Ocas, Kolbe Roche Fernández, Carmen Burgueño-Montañes, Edward Chavez-Cruzado, Tomas Galvez-Olortegui, Sebastian Videla, Jose Galvez-Olortegui

    Topic To assess the association between periodontal disease and glaucoma in adults through systematic review and meta-analysis of observational studies. Clinical relevance This study suggests that periodontal disease may increase the likelihood of developing glaucoma. Recognizing oral health as a potential modifiable risk factor could promote interdisciplinary prevention strategies and earlier detection of glaucoma in at-risk individuals. Methods This review followed PRISMA 2020 guidelines and was registered in PROSPERO (CRD42023428738). A systematic search was performed in PubMed/Medline, Scopus, Web of Science, Embase, Cochrane Library, LILACS, Google Scholar and journals with the highest impact in Ophthalmology, available until August 26th, 2025. Eligible articles were independently screened and quality assessed by three reviewers. All observational clinical studies reporting quantitative effect estimates and 95% confidence interval (95%CI) for the association between periodontal disease and glaucoma were included. Effect estimates for the association with glaucoma were pooled using random effects meta-analysis (Review Manager Version 5.4). Results 946 studies were screened, and 6 studies were included in the systematic review: 3 cohort studies, 1 nested case-control study and 2 cross-sectional studies. The populations evaluated were adults (n = 1,153,308). Different diagnostic methods were used for periodontal disease and glaucoma (clinical, self-reported, and disease classification codes), with variations in the criteria used and the type of glaucoma evaluated. Pooled effect estimates indicated a positive association between periodontal disease and glaucoma (OR: 1.72; 95%CI: 1.13–2.63; p-value: 0.010, I2: 99%). Conclusion The findings of this review, based on observational studies involving over one million individuals, suggest an association between periodontal disease and glaucoma. Patients with periodontal disease appear to be more likely to develop glaucoma than patients without it. However, additional long-term studies are needed.

  • Open Access

    Effectiveness and Safety of Mitomycin C in Deep Sclerectomy with the Esnoper Clip Implant: A Case Series Study

    by Rachid Bouchikh-El Jarroudi, Alina-Dana Baxant, Pavel Studeny, Kolbe Roche Fernández, Adrian Sanchez-Fortun-Sanchez, Martin Pencak, Jessica Botella-Garcia, Jordi Loscos-Arenas, Antoni Sabala Llopart, Sebastian Videla, et al.

    Objective: The objective was to provide evidence on the effectiveness (intraocular pressure, IOP) and safety of Deep Sclerectomy with the Esnoper Clip implant with and without the use of mitomycin C (MMC) in uncontrolled primary open-angle glaucoma. Methods: This was a multicentric, retrospective, consecutive case series study undertaken as a collaboration between University Hospital Trias i Pujol, Spain, and University Hospital Kralovske Vinohrady, Czech Republic. The IOP reduction was compared between patients who underwent Deep Sclerectomy with the Esnoper Clip implant, where the antifibrotic agent mitomycin C was used perioperatively (MMC group), and patients who underwent Deep Sclerectomy with Esnoper Clip implants where mitomycin C was not used either peri- or postoperatively (non-MMC group). At the end of the study (12 months after surgery), complete success probability (defined as an IOP p-value: 0.001; qualified success probability (95% confidence interval): 84.7% (76.6–93.7%) and 85.7% (75.8–97%), p-value: 0.188; and complications (total): 36 and 24, p-value: 0.286. Conclusions: In this case series study, the use of mitomycin C in Deep Sclerectomy with the Esnoper Clip implant for patients with uncontrolled primary open-angle glaucoma does not appear to improve IOP one year after surgery. No safety issues related to mitomycin C were observed. Further study is needed to confirm the effectiveness and to assess long-term safety.


  • Blepharospasm management in Schwartz-Jampel syndrome: A systematic review

    by Rachid Bouchikh-El Jarroudi, Kolbe Roche Fernández, Ester Casas-Gimeno, Hugo González-Valdivia, Carlos Ignacio Ortez-González, David Roche, Joan Prat-Bartomeu, Sebastian Videla

    Background: Blepharospasm is one of the most limiting symptoms in patients with Schwartz-Jampel syndrome and can affect early visual development, causing amblyopia and leading to disability. There is no consensus on the optimal management of blepharospasm in these patients. This systematic review aims to evaluate the current evidence for the appropriate management strategies for blepharospasm in Schwartz-Jampel syndrome. Methods: This was a prospective register of systematic reviews (PROSPERO)-registered (CRD42024569495), Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline-adherent systematic review. Databases searched include Medline (PubMed), Scopus, and Web of Science from any time to February 1st, 2025. All scientific manuscripts published discussing the management of blepharospasm in patients with Schwartz-Jampel syndrome were included. A novel therapeutic algorithm has been developed and proposed. Results: From an initial number of 59 articles, 15 of them were included. No clinical trials nor observational studies were found. All these 15 articles were case series or case reports (quality of evidence: 4 or 5), involving 21 patients. A great heterogeneity in how to manage blepharospasm in Schwartz-Jampel syndrome was gathered. Therapeutic options included oral drugs (sodium channel blockers: carbamazepine, phenytoin, and procainamide), botulinum-toxin-A, and eyelid surgery (orbicularis myectomy). The management algorithm proposal is oral sodium channel blockers as the first option and eyelid surgery as the second option treatment. Botulinum-toxin-A might be considered a therapeutic step prior to surgery. Conclusions: The published evidence regarding management strategies for blepharospasm in Schwartz-Jampel syndrome is scarce and of low quality. Since this nosology is a very rare disease, efforts should be promoted to conduct clinical research and a consensus document for the management of blepharospasm.


  • Open Access

    Biomechanical Corneal Parameters in Eyes With Chronic Ocular Hypotony and in Non-Hypotonic Eyes. Self-Controlled Case Series Study

    by Rachid Bouchikh-El Jarroudi, Kolbe Roche Fernández, Pau Romera Romero, Tatiana Croitoru-Croitoru, Anna Goñi-Guarro, Jessica Botella-Garcia, Antoni Sabala Llopart, Jordi Loscos-Arenas, Sebastian Videla

    Introduction: There are no available data concerning corneal parameters in patients with chronic ocular hypotony. Our purpose is to provide evidence and clinical correlation on the biomechanical corneal changes in chronic hypotonic eyes. Patients and Methods: A single-center, transversal, self-controlled case series study was conducted involving patients with at least one chronic hypotonic eye (defined as an intraocular pressure ≤ 6.5 mmHg measured on three separate occasions for at least three months). The chronic hypotonic eye was the case and the contralateral eye the control (non-hypotonic eye). We collected data from baseline characteristic and intraocular pressure (mmHg). Biomechanical corneal parameters measured by Corvis ST: deformation amplitude ratio (mm), Ambrósio’s relational thickness (μm), stiffness parameter at first applanation (mmHg/mm), Integrated radius (mm− 1), stress-strain index, pachymetry (μm), and in addition macular folds were recorded as well. A descriptive and exploratory analysis was performed. Results: Between November 2021 and July 2023, a total of 16 consecutive patients (7 men, 9 women; age [median (range)]: 72 (62– 84)), diagnosed with chronic ocular hypotony in one eye were included: 16 chronic hypotonic eyes and 16 non-hypotonic eyes. Hypotonic versus non-hypotonic eyes [median (range)]: intraocular pressure: 4 (2– 6) mmHg, 16 (8– 38) mmHg; deformation amplitude ratio: 5.6 (4.3– 6.6) mm, 4.7 (3.9– 5.5) mm, p-value= 0.002; Ambrósio’s relational thickness: 482 (263– 932) μm, 530 (210– 818) μm, p-value: 0.845; stiffness parameter at first applanation: 61.5 (39– 100) mmHg/mm, 113 (68– 130) mmHg/mm, p-value: < 0.001; Integrated radius: 10.9 mm− 1 (6.3– 16.8), 7.9 mm− 1 (6.4– 10.5), p-value: < 0.001; stress-strain index: 0.7 (− 0.2– 4.9), 1.1 (− 2.7– 5.6), p-value: 0.034; pachymetry 509 (456– 617) μm, 512 (436– 775) μm, p-value: 0.637; and macular folds: 7/16, 0/16, p-value: < 0.001. Conclusions: Chronic hypotonic eyes (eyes with a low intraocular pressure) present biomechanical corneal changes with respect to non-hypotonic eyes, mainly in deformation amplitude ratio, stiffness parameter at first applanation, stress-strain index and Ambrósio’s relational thickness parameters. These biomechanical corneal changes could reflect softer, more elastic and deformable scleras, which at its turn can bear higher risk of hypotony maculopathy.